BeOne Medicines Ltd. (ONC)
NASDAQ: ONC · Real-Time Price · USD
246.68
+6.27 (2.61%)
At close: May 29, 2025, 4:00 PM
241.89
-4.79 (-1.94%)
After-hours: May 29, 2025, 4:08 PM EDT

BeOne Medicines Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
30,33827,81117,4359,7667,4722,017
Upgrade
Revenue Growth (YoY)
52.09%59.51%78.53%30.69%270.56%-32.37%
Upgrade
Cost of Revenue
4,5694,3362,6941,9761,0488,915
Upgrade
Gross Profit
25,76923,47514,7417,7906,425-6,899
Upgrade
Selling, General & Admin
13,54513,37110,6998,8196,2903,918
Upgrade
Research & Development
14,32014,25712,61211,3159,270-
Upgrade
Operating Expenses
27,79427,62823,31120,13415,5653,924
Upgrade
Operating Income
-2,024-4,153-8,570-12,344-9,140-10,822
Upgrade
Interest Expense
-106.93-107.56-29.99-131.77-179.2-117.33
Upgrade
Interest & Investment Income
430.16456.72554.78493.7479.1130.37
Upgrade
Earnings From Equity Investments
-74.56-75-55.71-25.4-11.41-3.21
Upgrade
Other Non Operating Income (Expenses)
81.3353.66-279.99-1,34652.82166.49
Upgrade
EBT Excluding Unusual Items
-1,694-3,825-8,381-13,353-9,198-10,646
Upgrade
Gain (Loss) on Sale of Investments
-63.31-64.98-48.74-172.6959.6381.47
Upgrade
Gain (Loss) on Sale of Assets
0.39-----
Upgrade
Other Unusual Items
--2,573---
Upgrade
Pretax Income
-1,887-3,890-5,856-13,526-9,139-10,565
Upgrade
Income Tax Expense
978.1815.93396.18295.05122.1567.88
Upgrade
Earnings From Continuing Operations
-2,865-4,706-6,252-13,821-9,261-10,632
Upgrade
Minority Interest in Earnings
-----23.61
Upgrade
Net Income
-2,865-4,706-6,252-13,821-9,261-10,609
Upgrade
Net Income to Common
-2,865-4,706-6,252-13,821-9,261-10,609
Upgrade
Shares Outstanding (Basic)
1051051041039383
Upgrade
Shares Outstanding (Diluted)
1051051041039383
Upgrade
Shares Change (YoY)
0.78%0.86%1.22%11.15%11.16%38.99%
Upgrade
EPS (Basic)
-27.23-44.70-59.89-134.01-99.81-127.09
Upgrade
EPS (Diluted)
-27.23-44.70-59.89-134.01-99.81-127.09
Upgrade
Free Cash Flow
-1,548-4,622-12,192-12,567-9,921-9,146
Upgrade
Free Cash Flow Per Share
-14.71-43.90-116.79-121.85-106.92-109.57
Upgrade
Gross Margin
84.94%84.41%84.55%79.77%85.98%-
Upgrade
Operating Margin
-6.67%-14.93%-49.15%-126.40%-122.31%-536.69%
Upgrade
Profit Margin
-9.45%-16.92%-35.86%-141.52%-123.93%-526.10%
Upgrade
Free Cash Flow Margin
-5.10%-16.62%-69.93%-128.68%-132.76%-453.57%
Upgrade
EBITDA
-756.96-2,934-7,975-11,909-8,851-10,615
Upgrade
EBITDA Margin
-2.50%-10.55%-45.74%-121.94%-118.44%-
Upgrade
D&A For EBITDA
1,2681,219595.18434.89288.99207.54
Upgrade
EBIT
-2,024-4,153-8,570-12,344-9,140-10,822
Upgrade
EBIT Margin
-6.67%-14.93%-49.15%-126.40%-122.31%-
Upgrade
Revenue as Reported
27,64927,81117,4359,7667,4722,017
Upgrade
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q